135 related articles for article (PubMed ID: 15638778)
1. Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs.
Isaac M
Curr Top Med Chem; 2005; 5(1):59-67. PubMed ID: 15638778
[TBL] [Abstract][Full Text] [Related]
2. Serotonin and epilepsy.
Bagdy G; Kecskemeti V; Riba P; Jakus R
J Neurochem; 2007 Feb; 100(4):857-73. PubMed ID: 17212700
[TBL] [Abstract][Full Text] [Related]
3. Role of the 5-HT2C receptor in improving weight-supported stepping in adult rats spinalized as neonates.
Kao T; Shumsky JS; Jacob-Vadakot S; Himes BT; Murray M; Moxon KA
Brain Res; 2006 Sep; 1112(1):159-68. PubMed ID: 16914121
[TBL] [Abstract][Full Text] [Related]
4. Studies on the role of 5-HT2C and 5-HT2B receptors in regulating generalised seizure threshold in rodents.
Upton N; Stean T; Middlemiss D; Blackburn T; Kennett G
Eur J Pharmacol; 1998 Oct; 359(1):33-40. PubMed ID: 9831290
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of cerebellar 5-HT(2C) receptors in pilocarpine-induced epilepsy in rats: therapeutic role of Bacopa monnieri extract.
Krishnakumar A; Abraham PM; Paul J; Paulose CS
J Neurol Sci; 2009 Sep; 284(1-2):124-8. PubMed ID: 19439326
[TBL] [Abstract][Full Text] [Related]
6. The 5-HT2C receptor as a target for mood disorders.
Serretti A; Artioli P; De Ronchi D
Expert Opin Ther Targets; 2004 Feb; 8(1):15-23. PubMed ID: 14996615
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Selective 5-HT
Silenieks LB; Carroll NK; Van Niekerk A; Van Niekerk E; Taylor C; Upton N; Higgins GA
ACS Chem Neurosci; 2019 Jul; 10(7):3284-3295. PubMed ID: 31082204
[TBL] [Abstract][Full Text] [Related]
8. 5-HT(2C) receptor activation is a common mechanism on proerectile effects of apomorphine, oxytocin and melanotan-II in rats.
Kimura Y; Naitou Y; Wanibuchi F; Yamaguchi T
Eur J Pharmacol; 2008 Jul; 589(1-3):157-62. PubMed ID: 18582863
[TBL] [Abstract][Full Text] [Related]
9. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
10. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
11. Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse.
Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
Psychopharmacology (Berl); 2006 Mar; 185(1):45-57. PubMed ID: 16470405
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and its antithrombotic action in the cardiovascular system.
Reichenbach G; Momi S; Gresele P
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Feb; 5(1):65-74. PubMed ID: 15720224
[TBL] [Abstract][Full Text] [Related]
13. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
[TBL] [Abstract][Full Text] [Related]
15. Characterization of contractile 5-hydroxytryptamine receptor subtypes in the in situ autoperfused kidney in the anaesthetized rat.
Morán A; Ortiz de Urbina AV; Martín ML; García M; Rodriguez-Barbero A; Dorado F; San Román L
Eur J Pharmacol; 2008 Sep; 592(1-3):133-7. PubMed ID: 18644367
[TBL] [Abstract][Full Text] [Related]
16. Identification of dual role of piperazine-linked phenyl cyclopropyl methanone as positive allosteric modulator of 5-HT
Singh K; Sona C; Ojha V; Singh M; Mishra A; Kumar A; Siddiqi MI; Tripathi RP; Yadav PN
Eur J Med Chem; 2019 Feb; 164():499-516. PubMed ID: 30622024
[TBL] [Abstract][Full Text] [Related]
17. mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes.
Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
Neuropharmacology; 2004 Apr; 46(5):663-71. PubMed ID: 14996544
[TBL] [Abstract][Full Text] [Related]
18. Directly Observable Behavioral Effects of Lorcaserin in Rats.
Serafine KM; Rice KC; France CP
J Pharmacol Exp Ther; 2015 Dec; 355(3):381-5. PubMed ID: 26384326
[TBL] [Abstract][Full Text] [Related]
19. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders.
Wood MD
Curr Drug Targets CNS Neurol Disord; 2003 Dec; 2(6):383-7. PubMed ID: 14683466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
